Publicaciones en las que colabora con Ana María Giménez Arnau (21)

2024

  1. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513

  2. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Actas Dermo-Sifiliograficas

  3. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. 331-340

  4. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019–2022 prospective study with cluster and network analysis

    Journal of the European Academy of Dermatology and Venereology

  5. Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022)

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 486-494

  6. Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

    Actas Dermo-Sifiliograficas

2023

  1. Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain

    Journal of the European Academy of Dermatology and Venereology

  2. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain

    Dermatitis, Vol. 34, Núm. 4, pp. 315-322

  3. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

    Contact Dermatitis, Vol. 88, Núm. 3, pp. 212-219

2022

  1. [Translated article] Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 3, pp. T236-T243

2021

  1. Arguments in favour of excluding MDBGN from the European baseline series. In response to “Comment on MDBGN/DBDCB, the European baseline series, and EU legislation”

    Contact Dermatitis

  2. Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 9, pp. 798-805

  3. Comparative study of formaldehyde 2% in aqueous solution vs TRUE Test in detecting formaldehyde sensitization

    Contact Dermatitis, Vol. 85, Núm. 3, pp. 358-359

  4. Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Actas Dermo-Sifiliograficas

  5. Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA index

    Contact Dermatitis, Vol. 84, Núm. 6, pp. 395-406

  6. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study

    Contact dermatitis, Vol. 85, Núm. 5, pp. 572-577

2020

  1. Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 650-654

2019

  1. Patch testing with formaldehyde 2% aq. – A multicenter study in Spain

    Contact Dermatitis

  2. Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)

    Contact Dermatitis, Vol. 80, Núm. 2, pp. 94-100

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82